BRAIN, FOCUS & MOOD RESEARCH
A synthetic tuftsin analogue developed in Russia, studied for anti-anxiety and cognitive effects.
Selank is a synthetic analogue of tuftsin with an added anxiolytic sequence, developed in Russia as an anti-anxiety and cognitive-enhancing peptide. It has a documented Russian clinical-use history and is studied for calm focus, stress resilience, and mood.
Included because it has documented Russian clinical use—material foreign evidence—plus a described neuromodulatory mechanism and a consistent research-use history. Its clinical foundation places it above newer analogues without their own studies.
Modulates GABA, serotonin, and enkephalin systems.
Up-regulates BDNF and neurogenesis.
Balances immune response and lowers IL-6 inflammation; crosses the blood-brain barrier rapidly.
WHAT THE RESEARCH MEASURED
Findings describe study outcomes, not expected personal results.
Selank is used clinically in Russia and some other countries but is not FDA-approved. Sold and offered strictly for laboratory and research use.
